TH
Theralink Technologies, Inc.
THER · OTC
$0.00 +0.00% (+$0.00)
Market Cap $615.1K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 1.01x
P/FCF N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 49.60%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 978.62%
Op. margin 1,479.80%
Gross margin 79.20%
Quality
61 /100
Average ROA 1,084.55%
Asset turnover 0.21x
ROIC 75.37%
Debt
0 /100
High Int. coverage -0.53x
Current ratio 0.03x
Net debt/EBITDA N/A
Stability
1 /100
Unstable Profitable years 0
EPS volatility 84.78%
Beta 9.88x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na THER
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael I. Ruxin
Employees
16
Headquarters
Golden